vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.
MODIV INDUSTRIAL, INC. is the larger business by last-quarter revenue ($11.1M vs $9.2M, roughly 1.2× Foghorn Therapeutics Inc.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -234.3%, a 245.2% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -5.6%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -3.8%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
FHTX vs MDV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $11.1M |
| Net Profit | $-21.7M | $1.2M |
| Gross Margin | — | — |
| Operating Margin | -258.2% | 45.8% |
| Net Margin | -234.3% | 11.0% |
| Revenue YoY | 223.8% | -5.6% |
| Net Profit YoY | -11.1% | -22.0% |
| EPS (diluted) | $-0.35 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $11.1M | ||
| Q3 25 | $8.2M | $11.7M | ||
| Q2 25 | $7.6M | $11.8M | ||
| Q1 25 | $6.0M | $11.8M | ||
| Q4 24 | $2.9M | $11.7M | ||
| Q3 24 | $7.8M | $11.7M | ||
| Q2 24 | $6.9M | $11.4M | ||
| Q1 24 | $5.0M | $12.0M |
| Q4 25 | $-21.7M | $1.2M | ||
| Q3 25 | $-15.8M | $1.0M | ||
| Q2 25 | $-17.9M | $-2.0M | ||
| Q1 25 | $-18.8M | $829.0K | ||
| Q4 24 | $-19.5M | $1.6M | ||
| Q3 24 | $-19.1M | $-587.0K | ||
| Q2 24 | $-23.0M | $1.3M | ||
| Q1 24 | $-25.0M | $3.7M |
| Q4 25 | -258.2% | 45.8% | ||
| Q3 25 | -226.9% | 41.4% | ||
| Q2 25 | -279.2% | 9.8% | ||
| Q1 25 | -385.0% | 40.2% | ||
| Q4 24 | -840.5% | 45.4% | ||
| Q3 24 | -305.5% | 42.0% | ||
| Q2 24 | -386.6% | 44.6% | ||
| Q1 24 | -558.3% | 55.6% |
| Q4 25 | -234.3% | 11.0% | ||
| Q3 25 | -194.4% | 9.0% | ||
| Q2 25 | -237.3% | -17.1% | ||
| Q1 25 | -316.4% | 7.0% | ||
| Q4 24 | -682.9% | 13.3% | ||
| Q3 24 | -244.9% | -5.0% | ||
| Q2 24 | -333.6% | 11.6% | ||
| Q1 24 | -495.4% | 31.1% |
| Q4 25 | $-0.35 | $0.02 | ||
| Q3 25 | $-0.25 | $0.00 | ||
| Q2 25 | $-0.28 | $-0.32 | ||
| Q1 25 | $-0.30 | $-0.01 | ||
| Q4 24 | $-0.23 | $0.07 | ||
| Q3 24 | $-0.31 | $-0.18 | ||
| Q2 24 | $-0.45 | $0.03 | ||
| Q1 24 | $-0.59 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $14.4M |
| Total DebtLower is stronger | — | $261.5M |
| Stockholders' EquityBook value | $-108.5M | $162.7M |
| Total Assets | $198.1M | $476.5M |
| Debt / EquityLower = less leverage | — | 1.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $14.4M | ||
| Q3 25 | $89.3M | $8.3M | ||
| Q2 25 | $72.6M | $5.8M | ||
| Q1 25 | $61.0M | $6.2M | ||
| Q4 24 | $55.5M | $11.5M | ||
| Q3 24 | $57.7M | $6.8M | ||
| Q2 24 | $138.9M | $18.9M | ||
| Q1 24 | $79.3M | $18.4M |
| Q4 25 | — | $261.5M | ||
| Q3 25 | — | $279.7M | ||
| Q2 25 | — | $279.7M | ||
| Q1 25 | — | $279.7M | ||
| Q4 24 | — | $279.8M | ||
| Q3 24 | — | $279.7M | ||
| Q2 24 | — | $279.7M | ||
| Q1 24 | — | $279.6M |
| Q4 25 | $-108.5M | $162.7M | ||
| Q3 25 | $-89.7M | $164.8M | ||
| Q2 25 | $-76.7M | $165.6M | ||
| Q1 25 | $-61.7M | $171.1M | ||
| Q4 24 | $-45.5M | $190.1M | ||
| Q3 24 | $-28.3M | $186.3M | ||
| Q2 24 | $-14.3M | $187.0M | ||
| Q1 24 | $-97.5M | $188.0M |
| Q4 25 | $198.1M | $476.5M | ||
| Q3 25 | $205.0M | $499.6M | ||
| Q2 25 | $226.2M | $498.9M | ||
| Q1 25 | $258.7M | $506.8M | ||
| Q4 24 | $284.0M | $507.8M | ||
| Q3 24 | $308.4M | $507.4M | ||
| Q2 24 | $328.6M | $519.5M | ||
| Q1 24 | $255.0M | $522.5M |
| Q4 25 | — | 1.61× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | — | 1.50× | ||
| Q2 24 | — | 1.50× | ||
| Q1 24 | — | 1.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $15.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 12.34× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $15.0M | ||
| Q3 25 | $-18.9M | $4.1M | ||
| Q2 25 | $-21.0M | $3.9M | ||
| Q1 25 | $-24.0M | $3.0M | ||
| Q4 24 | $-24.5M | $18.2M | ||
| Q3 24 | $-21.0M | $5.1M | ||
| Q2 24 | $-25.5M | $4.7M | ||
| Q1 24 | $-29.3M | $3.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-21.3M | — | ||
| Q2 24 | $-25.6M | — | ||
| Q1 24 | $-29.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -278.2% | — | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | — | ||
| Q3 24 | -273.0% | — | ||
| Q2 24 | -371.0% | — | ||
| Q1 24 | -583.1% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 2.0% | — |
| Q4 25 | — | 12.34× | ||
| Q3 25 | — | 3.95× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.68× | ||
| Q4 24 | — | 11.72× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.55× | ||
| Q1 24 | — | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
